BECRO is participating as Exhibitor at CPhI Worldwide Frankfurt 2022 (1-3 November), Stand 91A68, Hall 9.1.
BECRO offers clinical trials services all the way from study set up to submission.
In addition, BECRO specializes in drafting modules of CDT and CERs for Medical Devices, and in preparing CDT and CDISC for US FDA submissions.
BECRO was inspected by US FDA, recently, and the outcome of the inspection was positive with No Observations. FDA conducted this inspection to “ensure that data and information submitted to FDA by BECRO are scientifically valid and reliable” and to determine whether the activities and procedures of BECRO complied with 21 CFR Part 320 – Bioavailability and Bioequivalence (BE).
BECRO invites you to the CPHI Worldwide 2022 in Frankfurt, Germany, from November 1–3, 2022.